How Does Hedonic Aroma Impact Long-Term Anxiety, Depression, and Quality of Life in Women with Breast Cancer? A Cross-Lagged Panel Model Analysis
Open Access
- 28 July 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (15) , 9260
Abstract
Depression and anxiety are common symptoms during and after adjuvant chemotherapy treatment for breast cancer (BC), with implications on quality of life (QoL). The present study evaluates the temporal relationship between anxiety, depression, and QoL (primary outcomes), as well as the impact of hedonic aroma (essential oils) on this relationship. This is a secondary analysis of a previously reported randomized controlled trial, with two groups: an experimental group (n = 56), who were subjected to the inhalation of a self-selected essential oil during chemotherapy, and a control group (n = 56), who were only subjected to the standard treatment. The hedonic aroma intervention occurred in the second (T1), third (T2), and fourth (T3) chemotherapy sessions, three weeks apart from each other. The follow-up (T4) assessments took place three months after the end of the treatment. Cross-lagged panel models were estimated in the path analysis framework, using structural equation modeling methodology. Regarding the control group, the cross-lagged panel model showed that anxiety at T1 predicted anxiety at T3, which in turn predicted both QoL and depression at T4. In the experimental group, hedonic aroma intervention was associated with stability of anxiety and QoL over time from T1 to T3, with no longitudinal prediction at T4. For women undergoing standard chemotherapy treatment, anxiety was the main longitudinal precursor to depression and QoL three months after chemotherapy. Thus, essential oils could complement chemotherapy treatment for early-stage BC as a way to improve long-term emotional and QoL-related adjustment.Keywords
Funding Information
- The Foundation for Science and Technology (FCT) (UIDB/PSI/01662/2020, SFRH/BD/137321/2018 PHD Fellowship, UIDB/00144/2020)
- the FCT (UIDB/PSI/01662/2020, SFRH/BD/137321/2018 PHD Fellowship, UIDB/00144/2020)
- Fundação para a Ciência e a Tecnologia (UIDB/PSI/01662/2020, SFRH/BD/137321/2018 PHD Fellowship, UIDB/00144/2020)
This publication has 47 references indexed in Scilit:
- Polypharmacy and the management of the older cancer patientAnnals of Oncology, 2013
- Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgeryBreast Cancer Research and Treatment, 2011
- Do low levels of stress reactivity signal poor states of health?Biological Psychology, 2011
- Short Assessment of Health Literacy—Spanish and English: A Comparable Test of Health Literacy for Spanish and English SpeakersHealth Services Research, 2010
- The transition from breast cancer ‘patient’ to ‘survivor’Psycho-Oncology, 2008
- Screeningtest des Geruchssinnes mit RiechdiskettenLaryngo-Rhino-Otologie, 1999
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications.Journal of Abnormal Psychology, 1991
- Transactional theory and research on emotions and copingEuropean Journal of Personality, 1987
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983